Biogen Inc
(XSWX:BIIB)
CHF
173.46
(0%)
Market Cap: 24.39 Bil
Enterprise Value: 26.25 Bil
PE Ratio: 21.69
PB Ratio: 1.60
GF Score: 69/100 Biogen Inc at Leerink CybeRx Series CNS Forum Transcript
Jun 23, 2020 / 04:30PM GMT
Release Date Price:
CHF232
Marc Harold Goodman
SVB Leerink LLC, Research Division - MD of Neuroscience & Senior Research Analyst
All right. Good afternoon, everybody. Welcome back. We are lucky enough for our next session to have Chris Henderson, who is the Head of Research at a little company called Biogen. And Chris, you've been in this new role now since March, but you have been in this organization for almost 6 years.
Questions & Answers
Marc Harold Goodman
SVB Leerink LLC, Research Division - MD of Neuroscience & Senior Research Analyst
So maybe you could just give us just a sense of behind the scenes at Biogen, talk about the general strategy of R&D there, your research capabilities, the R&D mantra, how maybe you're even different from a few other organizations, just quickly just set the stage?
Christopher Henderson
Biogen Inc. - VP & Head of Neuromuscular & Movement Disorders Research Unit
Yes, I think that's a really good way to start, actually, because I think our main mantra is what separates us
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot